[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 2433 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  1st Session
                                S. 2433

   To reauthorize certain programs under the Substance Use-Disorder 
Prevention that Promotes Opioid Recovery and Treatment for Patients and 
                Communities Act, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             July 20, 2023

  Mr. Cassidy introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
   To reauthorize certain programs under the Substance Use-Disorder 
Prevention that Promotes Opioid Recovery and Treatment for Patients and 
                Communities Act, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``SUPPORT for 
Patients and Communities Reauthorization Act of 2023''.
    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.
                       TITLE I--REAUTHORIZATIONS

Sec. 101. First responder training.
Sec. 102. Pilot program for public health laboratories to detect 
                            fentanyl and other synthetic opioids.
Sec. 103. Residential treatment programs for pregnant and postpartum 
                            women.
Sec. 104. Prenatal and postnatal health.
Sec. 105. Plans of safe care.
Sec. 106. Loan repayment program for substance use disorder treatment 
                            workforce.
Sec. 107. Youth prevention and recovery.
Sec. 108. Comprehensive opioid recovery centers.
Sec. 109. CDC surveillance and data collection for child, youth, and 
                            adult trauma.
Sec. 110. Task force to develop best practices for trauma-informed 
                            identification, referral, and support.
Sec. 111. Donald J. Cohen National child traumatic stress initiative.
Sec. 112. Surveillance and education regarding infections associated 
                            with illicit drug use and other risk 
                            factors.
Sec. 113. Building communities of recovery.
Sec. 114. Peer support technical assistance center.
Sec. 115. Preventing overdoses of controlled substances.
Sec. 116. CAREER Act.
                       TITLE II--OTHER PROVISIONS

Sec. 201. Delivery of a controlled substance by a pharmacy.
Sec. 202. Regulations relating to a special registration for 
                            telemedicine.
Sec. 203. Review of at-home drug disposal systems.
Sec. 204. Report on at-home drug disposal systems.
Sec. 205. Ensuring State choice in PDMP systems.
Sec. 206. Mental health parity.
Sec. 207. State guidance on coverage for individuals with serious 
                            mental illness and children with serious 
                            emotional disturbance.
Sec. 208. Community mental health services block grant service 
                            providers.
Sec. 209. Reports and studies on medication treatments for opioid use 
                            disorder.
Sec. 210. FASD Respect Act.

                       TITLE I--REAUTHORIZATIONS

SEC. 101. FIRST RESPONDER TRAINING.

    Section 546(h) of the Public Health Service Act (42 U.S.C. 290ee-
1(h)) is amended by striking ``2019 through 2023'' and inserting ``2024 
through 2028''.

SEC. 102. PILOT PROGRAM FOR PUBLIC HEALTH LABORATORIES TO DETECT 
              FENTANYL AND OTHER SYNTHETIC OPIOIDS.

    Section 7011(d) of the SUPPORT for Patients and Communities Act (42 
U.S.C. 247d-10 note) is amended by striking ``2019 through 2023'' and 
inserting ``2024 through 2028''.

SEC. 103. RESIDENTIAL TREATMENT PROGRAMS FOR PREGNANT AND POSTPARTUM 
              WOMEN.

    Section 508(s) of the Public Health Service Act (42 U.S.C. 290bb-
1(s)) is amended by striking ``2019 through 2023'' and inserting ``2024 
through 2028''.

SEC. 104. PRENATAL AND POSTNATAL HEALTH.

    Section 317L(d) of the Public Health Service Act (42 U.S.C. 247b-
13(d)) is amended by striking ``2019 through 2023'' and inserting 
``2024 through 2028''.

SEC. 105. PLANS OF SAFE CARE.

    Section 105(a)(7)(H) of the Child Abuse Prevention and Treatment 
Act (42 U.S.C. 5106(a)(7)(H)) is amended by striking ``2023'' and 
inserting ``2028''.

SEC. 106. LOAN REPAYMENT PROGRAM FOR SUBSTANCE USE DISORDER TREATMENT 
              WORKFORCE.

    Section 781(j) of the Public Health Service Act (42 U.S.C. 295h(j)) 
is amended by striking ``2019 through 2023'' and inserting ``2024 
through 2028''.

SEC. 107. YOUTH PREVENTION AND RECOVERY.

    Section 7102(c)(9) of the SUPPORT for Patients and Communities Act 
(42 U.S.C. 290bb-7a(c)(9)) is amended by striking ``2019 through 2023'' 
and inserting ``2024 through 2028''.

SEC. 108. COMPREHENSIVE OPIOID RECOVERY CENTERS.

    Section 552(j) of the Public Health Service Act (42 U.S.C. 290ee-
7(j)) is amended by striking ``2019 through 2023'' and inserting ``2024 
through 2028''.

SEC. 109. CDC SURVEILLANCE AND DATA COLLECTION FOR CHILD, YOUTH, AND 
              ADULT TRAUMA.

    Section 7131(e) of the SUPPORT for Patients and Communities Act (42 
U.S.C. 242t(e)) is amended by striking ``2019 through 2023'' and 
inserting ``2024 through 2028''.

SEC. 110. TASK FORCE TO DEVELOP BEST PRACTICES FOR TRAUMA-INFORMED 
              IDENTIFICATION, REFERRAL, AND SUPPORT.

    Section 7132(i) of the SUPPORT for Patients and Communities Act 
(Public Law 115-271) is amended by striking ``2023'' and inserting 
``2028''.

SEC. 111. DONALD J. COHEN NATIONAL CHILD TRAUMATIC STRESS INITIATIVE.

    Section 582(j) of the Public Health Service Act (42 U.S.C. 290hh-
1(j)) (relating to grants to address the problems of persons who 
experience violence-related stress) is amended by striking ``2019 
through 2023'' and inserting ``2024 through 2028''.

SEC. 112. SURVEILLANCE AND EDUCATION REGARDING INFECTIONS ASSOCIATED 
              WITH ILLICIT DRUG USE AND OTHER RISK FACTORS.

    Section 317N(d) of the Public Health Service Act (42 U.S.C. 247b-
15(d)) is amended by striking ``2019 through 2023'' and inserting 
``2024 through 2028''.

SEC. 113. BUILDING COMMUNITIES OF RECOVERY.

    Section 547(f) of the Public Health Service Act (42 U.S.C. 290ee-
2(f)) is amended by striking ``2019 through 2023'' and inserting ``2024 
through 2028''.

SEC. 114. PEER SUPPORT TECHNICAL ASSISTANCE CENTER.

    Section 547A(e) of the Public Health Service Act (42 U.S.C. 290ee-
2a(e)) is amended by striking ``2019 through 2023'' and inserting 
``2024 through 2028''.

SEC. 115. PREVENTING OVERDOSES OF CONTROLLED SUBSTANCES.

    Section 392A(e) of the Public Health Service Act (42 U.S.C. 280b-
1(e)) is amended by striking ``2019 through 2023'' and inserting ``2024 
through 2028''.

SEC. 116. CAREER ACT.

    Section 7183(k) of the SUPPORT for Patients and Communities Act (42 
U.S.C. 290ee-8(k)) is amended by striking ``2019 through 2023'' and 
inserting ``2024 through 2028''.

                       TITLE II--OTHER PROVISIONS

SEC. 201. DELIVERY OF A CONTROLLED SUBSTANCE BY A PHARMACY.

    Section 309A(a) of the Controlled Substances Act (21 U.S.C. 
829a(a)) is amended by striking paragraph (2) and inserting the 
following:
            ``(2) the controlled substance is a drug in schedule II, 
        III, IV, or V and is--
                    ``(A) to be administered for the purpose of 
                initiation, maintenance, or detoxification treatment; 
                or
                    ``(B) subject to conditions of approval imposed by 
                the Food and Drug Administration pursuant to section 
                505-1 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355-1), which may require the drug to be 
                administered with post-administration monitoring by a 
                health care professional;''.

SEC. 202. REGULATIONS RELATING TO A SPECIAL REGISTRATION FOR 
              TELEMEDICINE.

    Not later than 1 year after the date of enactment of this Act, the 
Attorney General, in consultation with the Secretary of Health and 
Human Services, shall promulgate the final regulations required under 
section 311(h)(2) of the Controlled Substances Act (21 U.S.C. 
831(h)(2)).

SEC. 203. REVIEW OF AT-HOME DRUG DISPOSAL SYSTEMS.

    Section 505-1 of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 355-1) is amended by adding at the end the following:
    ``(n) At-Home Drug Disposal Standards and Systems.--
            ``(1) Establishment of at-home drug disposal standards.--
        Not later than one year after the date of enactment of the 
        SUPPORT for Patients and Communities Reauthorization Act of 
        2023, the Secretary shall publish guidance to facilitate the 
        use of at-home safe disposal systems for drugs subject to a 
        risk evaluation and mitigation strategy that includes an 
        element described in subsection (e)(4).
            ``(2) Guidance.--The guidance under paragraph (1) shall 
        include--
                    ``(A) recommended standards for effective at-home 
                disposal systems to meet the public health or non-
                retrievability standard;
                    ``(B) recommended information to include as 
                instruction for use to disseminate with at-home 
                disposal systems; and
                    ``(C) best practices and educational tools to 
                support the use of an at-home disposal system.
            ``(3) Updates.--The Secretary shall update the guidance 
        under this subsection not less frequently than every 5 
        years.''.

SEC. 204. REPORT ON AT-HOME DRUG DISPOSAL SYSTEMS.

    Subsection (n) of section 505-1 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 355-1), as added by section 5, is amended by 
adding at the end the following:
            ``(4) Report on at-home drug disposal systems.--
                    ``(A) In general.--Not later than one year after 
                the date of enactment of the SUPPORT for Patients and 
                Communities Reauthorization Act of 2023, the Secretary, 
                in consultation with the Administrator of the Drug 
                Enforcement Administration, shall issue a report 
                outlining steps to improve access to at-home drug 
                disposal systems.
                    ``(B) Report.--The report required under 
                subparagraph (A) shall include--
                            ``(i) a review of commercially available 
                        at-home drug disposal systems;
                            ``(ii) current usage of at-home drug 
                        disposal systems;
                            ``(iii) any barriers to development, 
                        including information necessary to 
                        independently verify deactivation of 
                        appropriate drugs and challenges with real 
                        world testing;
                            ``(iv) any barriers to distribution of at-
                        home drug disposal systems; and
                            ``(v) best practices for educational 
                        resources to inform distribution and use of at-
                        home drug disposal systems.''.

SEC. 205. ENSURING STATE CHOICE IN PDMP SYSTEMS.

    Section 399O(h) of the Public Health Service Act (42 U.S.C. 280g-
3(h)) is amended by adding the following:
            ``(5) Ensuring state choice.--Nothing in this section shall 
        be construed to--
                    ``(A) direct, require or encourage a State to use a 
                specific interstate data sharing program;
                    ``(B) limit or prohibit the discretion of a PDMP to 
                utilize interoperability connections of its choice;
                    ``(C) permit, encourage, or otherwise condition 
                Federal financial assistance to States based upon the 
                use of open architecture by PDMP systems or contracted 
                vendors; or
                    ``(D) limit or prohibit the discretion of States to 
                utilize Federal financial assistance received under 
                this section to enter into arrangements with vendors of 
                their choice in order to carry out a program under this 
                section.''.

SEC. 206. MENTAL HEALTH PARITY.

    (a) In General.--Not later than January 1, 2025, the Inspector 
General of the Department of Labor, in coordination with the Inspector 
General of the Department of Health and Human Services, shall report to 
the Committee on Health, Education, Labor, and Pensions of the Senate 
and the Committee on Energy and Commerce and the Committee on Education 
and the Workforce of the House of Representatives on the following:
            (1) The non-quantitative treatment limit (referred to in 
        this section as ``NQTL'') requirements with respect to mental 
        health and substance use disorder benefits under group health 
        plans and health insurance issuers under section 2726(a)(8) of 
        the Public Health Service Act (42 U.S.C. 300gg-26(a)(8)), 
        section 712(a)(8) of the Employee Retirement Income Security 
        Act of 1974 (29 U.S.C. 1185a(a)(8)), and section 9812(a)(8) of 
        the Internal Revenue Code of 1986 (referred to in this section 
        as the ``NQTL comparative analysis requirements''), and the 
        requirements for the Secretary of Health and Human Services, 
        the Secretary of Labor, and the Secretary of the Treasury to 
        issue regulations, a compliance program guide, and additional 
        guidance documents and tools providing guidance relating to 
        mental health parity requirements under section 2726(a) of the 
        Public Health Service Act (42 U.S.C. 300gg-26(a)), section 
        712(a) of the Employee Retirement Income Security Act of 1974 
        (29 U.S.C. 1185a(a)), and section 9812(a) of the Internal 
        Revenue Code of 1986.
            (2) With respect to the NQTL comparative analysis 
        requirements described in paragraph (1), an analysis of the 
        actions taken by the Secretary of Labor, the Secretary of the 
        Treasury, and the Secretary of Health and Human Services to 
        provide guidance to ensure that group health plans and health 
        insurance issuers can fully comply with mental health parity 
        requirements under section 2726 of the Public Health Service 
        Act (42 U.S.C. 300gg-26, section 712 of the Employee Retirement 
        Income Security Act of 1974 (29 U.S.C. 1185a), and section 9812 
        of the Internal Revenue Code of 1986 and the NQTL comparative 
        analysis requirements described in paragraph (1), including an 
        analysis of--
                    (A) the extent to which the Secretary of Labor, the 
                Secretary of the Treasury, and the Secretary of Health 
                and Human Services have fulfilled the requirement under 
                section 203(b) of division BB of the Consolidated 
                Appropriations Act, 2021 (Public Law 116-260) to issue 
                the specific guidance and regulations pertaining to the 
                requirements for group health plans and health 
                insurance issuers to demonstrate compliance with the 
                NQTL comparative analysis requirements; and
                    (B) whether sufficient guidance and examples from 
                the Department of Labor and Department of Health and 
                Human Services, and the Department of the Treasury 
                exist to guide and assist group health plans and health 
                insurance issuers in complying with the requirements to 
                demonstrate compliance with mental health parity NQTL 
                comparative analysis requirements/under such sections 
                2726(a)(8), 712(a)(8), and 9812(a)(8).
            (3) A review of the enforcement processes of the Department 
        of Labor and the Department of Health and Human Services to 
        evaluate the consistency of interpretation of the requirements 
        under section 2726(a)(8) of the Public Health Service Act (42 
        U.S.C. 300gg-26(a)(8)), section 712(a)(8) of the Employee 
        Retirement Income Security Act of 1974 (29 U.S.C. 1185a(a)(8)), 
        and section 9812(a)(8) of the Internal Revenue Code of 1986, in 
        particular with respect to processes utilized for enforcement, 
        actions or inactions that constitute noncompliance, and 
        avoidance among the agencies of duplication of enforcement, 
        including an evaluation of compliance with section 104 of the 
        Health Insurance Portability and Accountability Act of 1996 
        (Public Law 104-191).
            (4) A review of the implementation, by the Department of 
        Labor, Department of Health and Human Services, and Department 
        of the Treasury, of mental health parity requirements under 
        section 2726 of the Public Health Service Act (42 U.S.C. 300gg-
        26), section 712 of the Employee Retirement Income Security Act 
        of 1974 (29 U.S.C. 1185a), and section 9812 of the Internal 
        Revenue Code of 1986, including all such requirements in effect 
        through the enactment of the Mental Health Parity Act of 1996 
        (Public Law 104-204), the Paul Wellstone and Pete Domenici 
        Mental Health Parity and Addiction Equity Act of 2008 (Public 
        Law 110-460), the 21st Century Cures Act (Public Law 114-255), 
        and the Consolidated Appropriations Act, 2023 (Public Law 117-
        328) (including any amendments made by such Acts), and 
        including with respect to the timing of all actions, delays of 
        any actions, reasons for any such delays, mandated requirements 
        that were met only once but not each time such requirements 
        were mandated.
    (b) Definitions.--In this section, the terms ``group health plan'' 
and ``health insurance issuer'' have the meanings given such terms in 
section 733 of the Employee Retirement Income Security Act of 1974 (29 
U.S.C. 1191b).

SEC. 207. STATE GUIDANCE ON COVERAGE FOR INDIVIDUALS WITH SERIOUS 
              MENTAL ILLNESS AND CHILDREN WITH SERIOUS EMOTIONAL 
              DISTURBANCE.

    (a) Review of Use of Certain Funding.--Not later than 180 days 
after the date of enactment of this Act, the Secretary of Health and 
Human Services, acting through the Assistant Secretary for Mental 
Health and Substance Use, shall conduct a review of the use by States 
of funds made available under the Community Mental Health Services 
Block Grant program under subpart I of part B of title XIX of the 
Public Health Service Act (42 U.S.C. 300x et seq.) for First Episode 
Psychosis activities. Such review shall consider the following:
            (1) How the States use funds for evidence-based treatments 
        and services according to the standard of care for individuals 
        with serious mental illness, including the comprehensiveness of 
        such treatments to include all aspects of the recommended 
        intervention.
            (2) How State mental health departments are coordinating 
        with State Medicaid departments in the delivery of the 
        treatments and services described in paragraph (1).
            (3) What percentage of the State funding under the block 
        grant program is being applied toward First Episode Psychosis 
        in excess of 10 percent of the amount of the grant, as broken 
        down on a State-by-State basis. The review shall also identify 
        any States that fail to expend the required 10 percent of block 
        grant funds on First Episode Psychosis activities.
            (4) How many individuals are served by the expenditures 
        described in paragraph (3), broken down on a per-capita basis.
            (5) How the funds are used to reach individuals in 
        underserved populations, including individuals in rural areas 
        and individuals from minority groups.
    (b) Report and Guidance.--
            (1) Report.--Not later than 6 months after the completion 
        of the review under subsection (a), the Secretary of Health and 
        Human Services, acting through the Assistant Secretary for 
        Mental Health and Substance Use, shall submit to the Committee 
        on Appropriations, the Committee on Health, Education, Labor, 
        and Pensions, and the Committee on Finance of the Senate and to 
        the Committee on Appropriations and the Committee on Energy and 
        Commerce of the House of Representatives a report on the 
        findings made as a result of the review conducted under 
        subsection (a). Such report shall include any recommendations 
        with respect to any changes to the Community Mental Health 
        Services Block Grant program, including the set aside required 
        for First Episode Psychosis, that would facilitate improved 
        outcomes for the targeted population involved.
            (2) Guidance.--Not later than 1 year after the date on 
        which the report is submitted under paragraph (1), the 
        Secretary of Health and Human Services, acting through the 
        Assistant Secretary for Mental Health and Substance Use, shall 
        update the guidance provided to States under the Community 
        Mental Health Services Block Grant program based on the 
        findings and recommendations of the report.
    (c) Technical Assistance.--The Director of the National Institute 
of Mental Health shall coordinate with the Assistant Secretary for 
Mental Health and Substance Use in providing technical assistance to 
State grantees and provider subgrantees in the delivery of services for 
First Episode Psychosis under the Community Mental Health Services 
Block Grant program.
    (d) Guidance for States Relating to Coverage Recommendations of 
Health Care Services and Interventions for Individuals With Serious 
Mental Illness and Children With Serious Emotional Disturbance.--Not 
later than 2 years after the date of enactment of this Act, the 
Administrator of the Centers for Medicare & Medicaid Services, jointly 
with the Assistant Secretary for Mental Health and Substance Use and 
the Director of the National Institute of Mental Health--
            (1) shall provide updated guidance to States concerning--
                    (A) coverage recommendations relating to health 
                care services and interventions for individuals with 
                serious mental illness, specifically First Episode 
                Psychosis; and
                    (B) the manner in which Federal funding provided to 
                States through programs administered by such agencies, 
                including the Community Mental Health Services Block 
                Grant program under subpart I of part B of title XIX of 
                the Public Health Service Act (42 U.S.C. 300x et seq.), 
                may be coordinated to support individuals with serious 
                mental illness and serious emotional disturbance; and
            (2) may streamline relevant State reporting requirements if 
        such streamlining would result in making it easier for States 
        to coordinate funding under the programs described in paragraph 
        (1)(B) to improve treatments for individuals with serious 
        mental illness and serious emotional disturbance.

SEC. 208. COMMUNITY MENTAL HEALTH SERVICES BLOCK GRANT SERVICE 
              PROVIDERS.

    Subpart I of part B of title XIX of the Public Health Service Act 
is amended--
            (1) in section 1913(b)(1) (42 U.S.C. 300x-2(b)(1)), by 
        inserting ``, and which may include, at the discretion of the 
        State, appropriate programs operated by for-profit entities'' 
        after ``consumer-directed programs''; and
            (2) in section 1916(a)(5) (42 U.S.C. 300x-5(a)(5)), by 
        inserting ``, or a for-profit entity selected by a State 
        pursuant to section 1913(b)(1)'' before the period at the end.

SEC. 209. REPORTS AND STUDIES ON MEDICATION TREATMENTS FOR OPIOID USE 
              DISORDER.

    (a) NIH Study on Methadone Treatment.--Not later than 6 months 
after the date of the enactment of this Act, and every 6 months 
thereafter, the Director of the National Institutes of Health--
            (1) shall submit to the Committee on Health, Education, 
        Labor, and Pensions of the Senate and the Committee on Energy 
        and Commerce of the House of Representatives a report on 
        ongoing and new clinical studies conducted or funded by the 
        National Institutes of Health on the access to, safety of, and 
        efficacy of methadone treatment for opioid use disorder in 
        accredited and certified opioid treatment programs and in other 
        programs or settings; and
            (2) in conjunction with the Administrator of the Drug 
        Enforcement Administration, shall brief the Committee on 
        Health, Education, Labor, and Pensions of the Senate and the 
        Committee on Energy and Commerce of the House of 
        Representatives on--
                    (A) interim results from the studies described in 
                paragraph (1); and
                    (B) any barriers that may prevent adequate and 
                timely enrollment of patients in any new clinical study 
                described in paragraph (1).
    (b) Study on Medication Treatments for Opioid Use Disorders.--The 
Secretary of Health and Human Services, acting through the Assistant 
Secretary for Mental Health and Substance Use, shall--
            (1) study--
                    (A) the early impact on access to medication 
                treatment for opioid use disorder and opioid-related 
                overdose deaths through buprenorphine prescribing 
                pursuant to section 303(g) of the Controlled Substances 
                Act (21 U.S.C. 823(g)), as amended by section 1262 of 
                title I of division FF of the Mental Health and Well-
                Being Act of 2022;
                    (B) an updated analysis of the effect of methadone 
                on opioid-related overdose death rates, disaggregated 
                by State;
                    (C) the number of patients with opioid use disorder 
                who are prescribed no medication for such disorder, and 
                the number of patients with opioid use disorder who are 
                prescribed naltrexone, buprenorphine, or methadone, 
                respectively, at each opioid treatment program;
                    (D) the prevalence of patients with opioid use 
                disorder, disaggregated by county and the number of 
                patients with opioid use disorder in each county;
                    (E) the number of addiction psychiatrists and 
                addiction medicine physicians within a county who are 
                not affiliated with an opioid treatment program and, 
                with respect to such psychiatrists and physicians--
                            (i) whether such providers accept new 
                        patients;
                            (ii) which types of health insurance are 
                        accepted by such providers; and
                            (iii) wait times for new appointments; and
                    (F) a survey of retail pharmacies nationwide, 
                disaggregated by State, to determine which pharmacies 
                serve as methadone dispensing units for opioid 
                treatment programs, and which such pharmacies are 
                interested in stocking or dispensing methadone; and
            (2) submit to the Committee on Health, Education, Labor, 
        and Pensions of the Senate and the Committee on Energy and 
        Commerce of the House of Representatives--
                    (A) not later than the earlier of 18 months after 
                the date of the enactment of this Act or June 1, 2025, 
                an initial report on the study under paragraph (1); and
                    (B) not later than December 31, 2025, a final 
                report on the study under paragraph (1).

SEC. 210. FASD RESPECT ACT.

    (a) In General.--Part O of title III of the Public Health Service 
Act (42 U.S.C. 280f et seq.) is amended--
            (1) by amending the part heading to read as follows: 
        ``fetal alcohol spectrum disorders prevention and services 
        program'';
            (2) in section 399H (42 U.S.C. 280f)--
                    (A) in the section heading, by striking 
                ``establishment of fetal alcohol syndrome prevention'' 
                and inserting ``fetal alcohol spectrum disorders 
                prevention, intervention,'';
                    (B) by striking ``Fetal Alcohol Syndrome and Fetal 
                Alcohol Effect'' each place it appears and inserting 
                ``FASD'';
                    (C) in subsection (a)--
                            (i) by amending the heading to read as 
                        follows: ``In General'';
                            (ii) in the matter preceding paragraph 
                        (1)--
                                    (I) by inserting ``or continue 
                                activities to support'' after ``shall 
                                establish'';
                                    (II) by striking ``FASD'' (as 
                                amended by subparagraph (B)) and 
                                inserting ``fetal alcohol spectrum 
                                disorders (referred to in this section 
                                as `FASD')'';
                                    (III) by striking ``prevention, 
                                intervention'' and inserting 
                                ``awareness, prevention, 
                                identification, intervention,''; and
                                    (IV) by striking ``that shall'' and 
                                inserting ``, which may'';
                            (iii) in paragraph (1)--
                                    (I) in subparagraph (A)--
                                            (aa) by striking ``medical 
                                        schools'' and inserting 
                                        ``health professions schools''; 
                                        and
                                            (bb) by inserting 
                                        ``infants,'' after ``provision 
                                        of services for''; and
                                    (II) in subparagraph (D), by 
                                striking ``medical and mental'' and 
                                inserting ``agencies providing'';
                            (iv) in paragraph (2)--
                                    (I) in the matter preceding 
                                subparagraph (A), by striking ``a 
                                prevention and diagnosis program to 
                                support clinical studies, 
                                demonstrations and other research as 
                                appropriate'' and inserting 
                                ``supporting and conducting research on 
                                FASD, as appropriate, including'';
                                    (II) in subparagraph (B)--
                                            (aa) by striking 
                                        ``prevention services and 
                                        interventions for pregnant, 
                                        alcohol-dependent women'' and 
                                        inserting ``culturally and 
                                        linguistically informed 
                                        evidence-based or practice-
                                        based interventions and 
                                        appropriate societal supports 
                                        for preventing prenatal alcohol 
                                        exposure, which may co-occur 
                                        with exposure to other 
                                        substances''; and
                                            (bb) by striking ``; and'' 
                                        and inserting a semicolon;
                            (v) by striking paragraph (3) and inserting 
                        the following:
            ``(3) integrating into surveillance practice an evidence-
        based standard case definition for fetal alcohol syndrome and, 
        in collaboration with other Federal and outside partners, 
        support organizations of appropriate medical and mental health 
        professionals in their development and refinement of evidence-
        based clinical diagnostic guidelines and criteria for all fetal 
        alcohol spectrum disorders; and
            ``(4) building State and Tribal capacity for the 
        identification, treatment, and support of individuals with FASD 
        and their families, which may include--
                    ``(A) utilizing and adapting existing Federal, 
                State, or Tribal programs to include FASD 
                identification and FASD-informed support;
                    ``(B) developing and expanding screening and 
                diagnostic capacity for FASD;
                    ``(C) developing, implementing, and evaluating 
                targeted FASD-informed intervention programs for FASD;
                    ``(D) increasing awareness of FASD;
                    ``(E) providing training with respect to FASD for 
                professionals across relevant sectors; and
                    ``(F) disseminating information about FASD and 
                support services to affected individuals and their 
                families.'';
                    (D) in subsection (b)--
                            (i) by striking ``described in section 
                        399I'';
                            (ii) by striking ``The Secretary'' and 
                        inserting the following:
            ``(1) In general.--The Secretary''; and
                            (iii) by adding at the end the following:
            ``(2) Eligible entities.--To be eligible to receive a 
        grant, or enter into a cooperative agreement or contract, under 
        this section, an entity shall--
                    ``(A) be a State, Indian Tribe or Tribal 
                organization, local government, scientific or academic 
                institution, or nonprofit organization; and
                    ``(B) prepare and submit to the Secretary an 
                application at such time, in such manner, and 
                containing such information as the Secretary may 
                require, including a description of the activities that 
                the entity intends to carry out using amounts received 
                under this section.
            ``(3) Additional application contents.--The Secretary may 
        require that an entity using amounts from a grant, cooperative 
        agreement, or contract under this section for an activity under 
        subsection (a)(4) include in the application for such amounts 
        submitted under paragraph (2)(B)--
                    ``(A) a designation of an individual to serve as a 
                FASD State or Tribal coordinator of such activity; and
                    ``(B) a description of an advisory committee the 
                entity will establish to provide guidance for the 
                entity on developing and implementing a statewide or 
                Tribal strategic plan to prevent FASD and provide for 
                the identification, treatment, and support of 
                individuals with FASD and their families.'';
                    (E) by striking subsections (c) and (d); and
                    (F) by adding at the end the following:
    ``(c) Definition of FASD-Informed.--For purposes of this section, 
the term `FASD-informed', with respect to support or an intervention 
program, means that such support or intervention program uses 
culturally and linguistically informed evidence-based or practice-based 
interventions and appropriate societal supports to support an improved 
quality of life for an individual with FASD and the family of such 
individual.''; and
            (3) by striking sections 399I, 399J, and 399K (42 U.S.C. 
        280f-1, 280f-2, 280f-3) and inserting the following:

``SEC. 399I. FETAL ALCOHOL SPECTRUM DISORDERS CENTERS FOR EXCELLENCE.

    ``(a) In General.--The Secretary shall, as appropriate, award 
grants, cooperative agreements, or contracts to public or nonprofit 
entities with demonstrated expertise in the prevention of, 
identification of, and intervention services with respect to, fetal 
alcohol spectrum disorders (referred to in this section as `FASD') and 
other related adverse conditions. Such awards shall be for the purposes 
of establishing Fetal Alcohol Spectrum Disorders Centers for Excellence 
to build local, Tribal, State, and national capacities to prevent the 
occurrence of FASD and other related adverse conditions, and to respond 
to the needs of individuals with FASD and their families by carrying 
out the programs described in subsection (b).
    ``(b) Programs.--An entity receiving an award under subsection (a) 
may use such award for the following purposes:
            ``(1) Initiating or expanding diagnostic capacity for FASD 
        by increasing screening, assessment, identification, and 
        diagnosis.
            ``(2) Developing and supporting public awareness and 
        outreach activities, including the use of a range of media and 
        public outreach, to raise public awareness of the risks 
        associated with alcohol consumption during pregnancy, with the 
        goals of reducing the prevalence of FASD and improving the 
        developmental, health (including mental health), and 
        educational outcomes of individuals with FASD and supporting 
        families caring for individuals with FASD.
            ``(3) Acting as a clearinghouse for evidence-based 
        resources on FASD prevention, identification, and culturally 
        and linguistically informed best practices, including the 
        maintenance of a national data-based directory on FASD-specific 
        services in States, Indian Tribes, and local communities, and 
        disseminating ongoing research and developing resources on FASD 
        to help inform systems of care for individuals with FASD across 
        their lifespan.
            ``(4) Increasing awareness and understanding of 
        efficacious, evidence-based FASD screening tools and 
        culturally- and linguistically-appropriate evidence-based 
        intervention services and best practices, which may include by 
        conducting national, regional, State, Tribal, or peer cross-
        State webinars, workshops, or conferences for training 
        community leaders, medical and mental health and substance use 
        disorder professionals, education and disability professionals, 
        families, law enforcement personnel, judges, individuals 
        working in financial assistance programs, social service 
        personnel, child welfare professionals, and other service 
        providers.
            ``(5) Improving capacity for State, Tribal, and local 
        affiliates dedicated to FASD awareness, prevention, and 
        identification and family and individual support programs and 
        services.
            ``(6) Providing technical assistance to grantees under 
        section 399H, as appropriate.
            ``(7) Carrying out other functions, as appropriate.
    ``(c) Application.--To be eligible for a grant, contract, or 
cooperative agreement under this section, an entity shall submit to the 
Secretary an application at such time, in such manner, and containing 
such information as the Secretary may require.
    ``(d) Subcontracting.--A public or private nonprofit entity may 
carry out the following activities required under this section through 
contracts or cooperative agreements with other public and private 
nonprofit entities with demonstrated expertise in FASD:
            ``(1) Prevention activities.
            ``(2) Screening and identification.
            ``(3) Resource development and dissemination, training and 
        technical assistance, administration, and support of FASD 
        partner networks.
            ``(4) Intervention services.

``SEC. 399J. AUTHORIZATION OF APPROPRIATIONS.

    ``There are authorized to be appropriated to carry out this part 
such sums as may be necessary for each of fiscal years 2024 through 
2028.''.
    (b) Report.--Not later than 4 years after the date of enactment of 
this Act, the Secretary of Health and Human Services shall submit to 
the Committee on Health, Education, Labor, and Pensions of the Senate 
and the Committee on Energy and Commerce of the House of 
Representatives a report on the efforts of the Department of Health and 
Human Services to advance public awareness on, and facilitate the 
identification of best practices related to, fetal alcohol spectrum 
disorders identification, prevention, treatment, and support.
    (c) Technical Amendment.--Section 519D of the Public Health Service 
Act (42 U.S.C. 290bb-25d) is repealed.
                                 <all>